US$ 25.01
tirzepatide in mounjaro 2.5 mg / 0.5 ml Vial - Mounjaro | American Diabetes Association
Description
Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, representing a novel class of incretin-based research compounds

Sometimes, thirst can be mistaken for hunger, leading to unnecessary snacking

Smaller doses (0.25 mg, 0.5 mg, and 1 mg) cost $349 a month for existing patients
This protein helps preserve muscle and keep you full when you're in a calorie deficit

The strongest interactions were observed between these compounds and receptor A, while anthraquinone exhibited significant binding affinity for receptor B
